{
    "clinical_study": {
        "@rank": "80747", 
        "arm_group": [
            {
                "arm_group_label": "Office visit-based intervention", 
                "arm_group_type": "Experimental"
            }, 
            {
                "arm_group_label": "Electronic message-based intervention", 
                "arm_group_type": "Experimental"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this project is to compare two pharmacist-led population management\n      strategies designed to increase the rate of appropriate monitoring of vitamin B12 and serum\n      creatinine for patients taking metformin."
        }, 
        "brief_title": "Comparison of Two Pharmacist-led Population Management Approaches to Increase Monitoring of Vitamin B12 and Serum Creatinine Levels for Patients on Metformin", 
        "completion_date": {
            "#text": "August 2014", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Type 2 Diabetes", 
            "Vitamin B12 Deficiency", 
            "Neuropathy", 
            "Anemia"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Anemia", 
                "Diabetes Mellitus, Type 2", 
                "Vitamin B 12 Deficiency"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  On Metformin for at least one year\n\n          -  Activated patient portal for electronic messaging\n\n          -  Patient of an attending physician at Ohio State General Internal Medicine\n\n          -  No serum vitamin B12 and/or no serum creatinine measurement in the past year"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "500", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "February 26, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02076347", 
            "org_study_id": "2013H0307"
        }, 
        "intervention": [
            {
                "arm_group_label": "Office visit-based intervention", 
                "description": "Pharmacist communicates monitoring recommendations to physician through the electronic medical record prior to a scheduled patient office visit", 
                "intervention_name": "Office visit intervention", 
                "intervention_type": "Behavioral"
            }, 
            {
                "arm_group_label": "Electronic message-based intervention", 
                "description": "Pharmacist communicates need for monitoring directly to patients and instructs them to obtain monitoring on their own time without need for an office visit with physician", 
                "intervention_name": "Electronic Message Intervention", 
                "intervention_type": "Behavioral"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Vitamin B 12", 
                "Hydroxocobalamin", 
                "Vitamin B Complex", 
                "Vitamins", 
                "Metformin"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Metformin", 
            "Vitamin B12 Deficiency", 
            "Population Management", 
            "Pharmacist"
        ], 
        "lastchanged_date": "February 27, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Columbus", 
                    "country": "United States", 
                    "state": "Ohio", 
                    "zip": "43221"
                }, 
                "name": "The Ohio State University General Internal Medicine"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "Comparison of Two Pharmacist-led Population Management Approaches to Increase Monitoring of Vitamin B12 and Serum Creatinine Levels for Patients on Metformin", 
        "overall_status": "Enrolling by invitation", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "August 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Percentage of patients in each arm who obtain monitoring of vitamin B12 as recommended", 
            "safety_issue": "Yes", 
            "time_frame": "6 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02076347"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Ohio State University", 
            "investigator_full_name": "Kelli Barnes", 
            "investigator_title": "Assistant Professor of Clinical Pharmacy", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "measure": "Number of patients with newly identified vitamin B12 deficiency", 
                "safety_issue": "Yes", 
                "time_frame": "6 months"
            }, 
            {
                "description": "When a patient's serum vitamin B12 level comes back and is low the chart will be reviewed immediately to determine this. This could happen anytime during the 6 month study period.", 
                "measure": "Percentage of patients with newly identified vitamin B12 deficiency who have prior evidence of anemia upon chart review", 
                "safety_issue": "Yes", 
                "time_frame": "within 6 months"
            }, 
            {
                "description": "When a patient's serum vitamin B12 level comes back and is low the chart will be reviewed immediately to determine if neuropathy is also listed as a medical problem. This could happen anytime during the 6 month study period.", 
                "measure": "Percentage of patients with newly identified vitamin B12 deficiency who have prior evidence of neuropathy upon chart review", 
                "safety_issue": "Yes", 
                "time_frame": "within 6 months"
            }
        ], 
        "source": "Ohio State University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Ohio State University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "February 2014", 
        "study_design": "Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Screening", 
        "study_type": "Interventional", 
        "verification_date": "February 2014"
    }
}